266 related articles for article (PubMed ID: 19167883)
61. Design, synthesis and biological evaluation of 3-substituted 2,5-dimethyl-N-(3-(1H-tetrazol-5-yl)phenyl)pyrroles as novel potential HIV-1 gp41 inhibitors.
He XY; Zou P; Qiu J; Hou L; Jiang S; Liu S; Xie L
Bioorg Med Chem; 2011 Nov; 19(22):6726-34. PubMed ID: 22014749
[TBL] [Abstract][Full Text] [Related]
62. Investigation of the structural requirement for inhibiting HIV integrase: QSAR study.
Dessalew N
Acta Pharm; 2009 Mar; 59(1):31-43. PubMed ID: 19304556
[TBL] [Abstract][Full Text] [Related]
63. Synthesis and anti-HIV-1 integrase activity of cyano pyrimidinones.
Ramajayam R; Mahera NB; Neamati N; Yadav MR; Giridhar R
Arch Pharm (Weinheim); 2009 Dec; 342(12):710-5. PubMed ID: 19899101
[TBL] [Abstract][Full Text] [Related]
64. Novel Benzoxazin-3-one Derivatives: Design, Synthesis, Molecular Modeling, Anti-HIV-1 and Integrase Inhibitory Assay.
Safakish M; Hajimahdi Z; Vahabpour R; Zabihollahi R; Zarghi A
Med Chem; 2020; 16(7):938-946. PubMed ID: 31448713
[TBL] [Abstract][Full Text] [Related]
65. 8-Hydroxy-3,4-dihydropyrrolo[1,2-a]pyrazine-1(2H)-one HIV-1 integrase inhibitors.
Fisher TE; Kim B; Staas DD; Lyle TA; Young SD; Vacca JP; Zrada MM; Hazuda DJ; Felock PJ; Schleif WA; Gabryelski LJ; Anari MR; Kochansky CJ; Wai JS
Bioorg Med Chem Lett; 2007 Dec; 17(23):6511-5. PubMed ID: 17931865
[TBL] [Abstract][Full Text] [Related]
66. Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidones.
Gardelli C; Nizi E; Muraglia E; Crescenzi B; Ferrara M; Orvieto F; Pace P; Pescatore G; Poma M; Ferreira Mdel R; Scarpelli R; Homnick CF; Ikemoto N; Alfieri A; Verdirame M; Bonelli F; Paz OG; Taliani M; Monteagudo E; Pesci S; Laufer R; Felock P; Stillmock KA; Hazuda D; Rowley M; Summa V
J Med Chem; 2007 Oct; 50(20):4953-75. PubMed ID: 17824681
[TBL] [Abstract][Full Text] [Related]
67. Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groups.
Johns BA; Kawasuji T; Weatherhead JG; Boros EE; Thompson JB; Koble CS; Garvey EP; Foster SA; Jeffrey JL; Fujiwara T
Bioorg Med Chem Lett; 2014 Jul; 24(14):3104-7. PubMed ID: 24908608
[TBL] [Abstract][Full Text] [Related]
68. Coumarin-based inhibitors of HIV integrase.
Zhao H; Neamati N; Hong H; Mazumder A; Wang S; Sunder S; Milne GW; Pommier Y; Burke TR
J Med Chem; 1997 Jan; 40(2):242-9. PubMed ID: 9003523
[TBL] [Abstract][Full Text] [Related]
69. Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors.
Pace P; Di Francesco ME; Gardelli C; Harper S; Muraglia E; Nizi E; Orvieto F; Petrocchi A; Poma M; Rowley M; Scarpelli R; Laufer R; Gonzalez Paz O; Monteagudo E; Bonelli F; Hazuda D; Stillmock KA; Summa V
J Med Chem; 2007 May; 50(9):2225-39. PubMed ID: 17428043
[TBL] [Abstract][Full Text] [Related]
70. Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation.
Zeng LF; Jiang XH; Sanchez T; Zhang HS; Dayam R; Neamati N; Long YQ
Bioorg Med Chem; 2008 Aug; 16(16):7777-87. PubMed ID: 18644730
[TBL] [Abstract][Full Text] [Related]
71. Synthesis and HIV-1 integrase inhibitory activities of caffeoylglucosides.
Kim SN; Lee JY; Kim HJ; Shin CG; Park H; Lee YS
Bioorg Med Chem Lett; 2000 Aug; 10(16):1879-82. PubMed ID: 10969990
[TBL] [Abstract][Full Text] [Related]
72. Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonists.
Rotstein DM; Melville CR; Padilla F; Cournoyer D; Lee EK; Lemoine R; Petersen AC; Setti LQ; Wanner J; Chen L; Filonova L; Loughhead DG; Manka J; Lin XF; Gleason S; Sankuratri S; Ji C; Derosier A; Dioszegi M; Heilek G; Jekle A; Berry P; Mau CI; Weller P
Bioorg Med Chem Lett; 2010 May; 20(10):3116-9. PubMed ID: 20417098
[TBL] [Abstract][Full Text] [Related]
73. A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series.
De Luca L; Barreca ML; Ferro S; Iraci N; Michiels M; Christ F; Debyser Z; Witvrouw M; Chimirri A
Bioorg Med Chem Lett; 2008 May; 18(9):2891-5. PubMed ID: 18417342
[TBL] [Abstract][Full Text] [Related]
74. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
Plewe MB; Butler SL; Dress KR; Hu Q; Johnson TW; Kuehler JE; Kuki A; Lam H; Liu W; Nowlin D; Peng Q; Rahavendran SV; Tanis SP; Tran KT; Wang H; Yang A; Zhang J
J Med Chem; 2009 Nov; 52(22):7211-9. PubMed ID: 19873974
[TBL] [Abstract][Full Text] [Related]
75. New 4-[(1-benzyl-1H-indol-3-yl)carbonyl]-3-hydroxyfuran-2(5H)-ones, beta-diketo acid analogs as HIV-1 integrase inhibitors.
Ferro S; Barreca ML; De Luca L; Rao A; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
Arch Pharm (Weinheim); 2007 Jun; 340(6):292-8. PubMed ID: 17562561
[TBL] [Abstract][Full Text] [Related]
76. A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cells.
Embrey MW; Wai JS; Funk TW; Homnick CF; Perlow DS; Young SD; Vacca JP; Hazuda DJ; Felock PJ; Stillmock KA; Witmer MV; Moyer G; Schleif WA; Gabryelski LJ; Jin L; Chen IW; Ellis JD; Wong BK; Lin JH; Leonard YM; Tsou NN; Zhuang L
Bioorg Med Chem Lett; 2005 Oct; 15(20):4550-4. PubMed ID: 16102965
[TBL] [Abstract][Full Text] [Related]
77. Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.
Borthwick AD; Davies DE; Ertl PF; Exall AM; Haley TM; Hart GJ; Jackson DL; Parry NR; Patikis A; Trivedi N; Weingarten GG; Woolven JM
J Med Chem; 2003 Oct; 46(21):4428-49. PubMed ID: 14521407
[TBL] [Abstract][Full Text] [Related]
78. Synthesis and anti-HIV activity of alkylated quinoline 2,4-diols.
Ahmed N; Brahmbhatt KG; Sabde S; Mitra D; Singh IP; Bhutani KK
Bioorg Med Chem; 2010 Apr; 18(8):2872-9. PubMed ID: 20350812
[TBL] [Abstract][Full Text] [Related]
79. Design and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl DPP-IV inhibitors.
Corbett JW; Dirico K; Song W; Boscoe BP; Doran SD; Boyer D; Qiu X; Ammirati M; Vanvolkenburg MA; McPherson RK; Parker JC; Cox ED
Bioorg Med Chem Lett; 2007 Dec; 17(24):6707-13. PubMed ID: 17977724
[TBL] [Abstract][Full Text] [Related]
80. Dihydroxy-pyrimidine and N-methylpyrimidone HIV-integrase inhibitors: improving cell based activity by the quaternarization of a chiral center.
Nizi E; Orsale MV; Crescenzi B; Pescatore G; Muraglia E; Alfieri A; Gardelli C; Spieser SA; Summa V
Bioorg Med Chem Lett; 2009 Aug; 19(16):4617-21. PubMed ID: 19616948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
